Autophagy Neurotherapeutics, Inc., is located at Florida International University, Miami, FL, and is focused on drugs for treating ALS, Alzheimer’s and other neuro-degenerative diseases. The effort is to modulate autophagy, which is the brain’s system for eliminating toxic proteins. It is emerging as one of the best ways to develop drugs for all neurodegenerative diseases. The co.'s 2 drugs, TPI-132 and THPI-244, look very promising.